Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-20

Clinical Trial Update: Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating three Lachrymal substitute formulations on tear film thickness and signs/symptoms in moderate to severe dry eye syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of Vienna | Conditions: Dry Eye Syndromes | Phase 4 | Status: COMPLETED